Nelson K - Search Results

1

Publication of original research in urologic journals--a neglected orphan?

Mani J, Makarević J, Juengel E, Ackermann H, Nelson K, Haferkamp A, Blaheta RA. Mani J, et al. Among authors: nelson k. PLoS One. 2012;7(12):e52420. doi: 10.1371/journal.pone.0052420. Epub 2012 Dec 19. PLoS One. 2012. PMID: 23285032 Free PMC article.

2

Globalization in Urology: A Bibliographical Analysis of Cross-Continent Publication between 2002 and 2012.

Mani J, Juengel E, Bartsch G, Filmann N, Ackermann H, Nelson K, Haferkamp A, Engl T, Blaheta RA. Mani J, et al. Among authors: nelson k. Urol Int. 2015;95(3):281-7. doi: 10.1159/000438830. Epub 2015 Sep 9. Urol Int. 2015. PMID: 26346650

3

I publish in I edit?--Do editorial board members of urologic journals preferentially publish their own scientific work?

Mani J, Makarević J, Juengel E, Ackermann H, Nelson K, Bartsch G, Haferkamp A, Blaheta RA. Mani J, et al. Among authors: nelson k. PLoS One. 2013 Dec 27;8(12):e83709. doi: 10.1371/journal.pone.0083709. eCollection 2013. PLoS One. 2013. PMID: 24386258 Free PMC article.

4

Amygdalin influences bladder cancer cell adhesion and invasion in vitro.

Makarević J, Rutz J, Juengel E, Kaulfuss S, Tsaur I, Nelson K, Pfitzenmaier J, Haferkamp A, Blaheta RA. Makarević J, et al. Among authors: nelson k. PLoS One. 2014 Oct 15;9(10):e110244. doi: 10.1371/journal.pone.0110244. eCollection 2014. PLoS One. 2014. PMID: 25333694 Free PMC article.

5

Use of complementary and alternative medicine before and after organ removal due to urologic cancer.

Mani J, Juengel E, Arslan I, Bartsch G, Filmann N, Ackermann H, Nelson K, Haferkamp A, Engl T, Blaheta RA. Mani J, et al. Among authors: nelson k. Patient Prefer Adherence. 2015 Oct 1;9:1407-12. doi: 10.2147/PPA.S90061. eCollection 2015. Patient Prefer Adherence. 2015. PMID: 26491269 Free PMC article.

6

Amygdalin, quackery or cure?

Blaheta RA, Nelson K, Haferkamp A, Juengel E. Blaheta RA, et al. Among authors: nelson k. Phytomedicine. 2016 Apr 15;23(4):367-76. doi: 10.1016/j.phymed.2016.02.004. Epub 2016 Feb 17. Phytomedicine. 2016. PMID: 27002407 Review.

7

Resistance after chronic application of the HDAC-inhibitor valproic acid is associated with elevated Akt activation in renal cell carcinoma in vivo.

Juengel E, Makarević J, Tsaur I, Bartsch G, Nelson K, Haferkamp A, Blaheta RA. Juengel E, et al. Among authors: nelson k. PLoS One. 2013;8(1):e53100. doi: 10.1371/journal.pone.0053100. Epub 2013 Jan 23. PLoS One. 2013. PMID: 23372654 Free PMC article.

8

HDAC-inhibition counteracts everolimus resistance in renal cell carcinoma in vitro by diminishing cdk2 and cyclin A.

Juengel E, Nowaz S, Makarevi J, Natsheh I, Werner I, Nelson K, Reiter M, Tsaur I, Mani J, Harder S, Bartsch G, Haferkamp A, Blaheta RA. Juengel E, et al. Among authors: nelson k. Mol Cancer. 2014 Jun 16;13:152. doi: 10.1186/1476-4598-13-152. Mol Cancer. 2014. PMID: 24935000 Free PMC article.

9

CCL2 promotes integrin-mediated adhesion of prostate cancer cells in vitro.

Tsaur I, Rutz J, Makarević J, Juengel E, Gust KM, Borgmann H, Schilling D, Nelson K, Haferkamp A, Bartsch G, Blaheta RA. Tsaur I, et al. Among authors: nelson k. World J Urol. 2015 Jul;33(7):1051-6. doi: 10.1007/s00345-014-1389-z. Epub 2014 Sep 2. World J Urol. 2015. PMID: 25179012

10

Intensified antineoplastic effect by combining an HDAC-inhibitor, an mTOR-inhibitor and low dosed interferon alpha in prostate cancer cells.

Tsaur I, Hudak L, Makarević J, Juengel E, Mani J, Borgmann H, Gust KM, Schilling D, Bartsch G, Nelson K, Haferkamp A, Blaheta RA. Tsaur I, et al. Among authors: nelson k. J Cell Mol Med. 2015 Aug;19(8):1795-804. doi: 10.1111/jcmm.12583. Epub 2015 Mar 26. J Cell Mol Med. 2015. PMID: 25808196 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,979 results

Search Page